First report of an IDE pivotal study of a dedicated splitting device during TAVR

PCR Perspectives

Summary

Watch this interview in which Christopher Cook hosts Martin Leon to discuss pivotal study data on the ShortCut dedicated leaflet splitting device. They revisit the unmet clinical need for leaflet splitting during TAVR: transcatheter valve failures, noting that transcatheter valve failures could surpass surgical bioprosthetic valve failures by 2028. Martin Leon also outlines the design of this observational prospective study in high-risk patients for coronary obstruction, he introduces the mechanical device and reveals key study findings.

This interview was filmed at EuroPCR 2024: see more videos here.